Home » The company’s controlling shareholder’s equity change violates regulations. Landun shares receive a supervisory letter from the Shenzhen Stock Exchange | Landun shares | supervisory letter | equity changes_Sina Technology

The company’s controlling shareholder’s equity change violates regulations. Landun shares receive a supervisory letter from the Shenzhen Stock Exchange | Landun shares | supervisory letter | equity changes_Sina Technology

by admin


Original title: The company’s controlling shareholder’s equity changes violated the regulations, Blue Shield shares received the Shenzhen Stock Exchange regulatory letter

On November 30, the information security company Blue Shield Co., Ltd. received a regulatory letter issued by the Shenzhen Stock Exchange due to a violation of the controlling shareholder’s equity change.

The regulatory letter pointed out that Blue Shield Co., Ltd. disclosed the “Short Form Report on Changes in Equity” on November 23, 2021. Based on the “Short Form Report on Changes in Equity” disclosed by the company on December 28, 2019, the company’s controlling shareholders, unanimous The actors Ke Zongqing, Ke Zonggui, and Zhongjing Huitong Co., Ltd. total held the company’s shares from 416,468,839 shares to 343,618,510 shares, and the share change ratio was 5.83%. However, when the total shareholding ratio of the company changed by 5%, it did not stop buying and selling the company’s shares and disclosed the short form equity change report in a timely manner. The Shenzhen Stock Exchange pointed out that the above behavior violated relevant regulations and required it to pay full attention to the above problems, learn lessons, and rectify in a timely manner to prevent the recurrence of the above problems.

Recently, Blue Shield shares and its controlling shareholders Ke Zongqing and Ke Zonggui have been turbulent. Due to the inaccurate and incomplete disclosure of the performance forecast information, Blue Shield received a warning letter from the Sichuan Regulatory Bureau of the China Securities Regulatory Commission in September. On October 21, Blue Shield, the company’s then chairman Ke Zongqing, and the company’s current chairman Ke Zonggui and the current president Ke Zonggui Chief Financial Officer Jing Li was publicly condemned and punished by the Shenzhen Stock Exchange.

See also  The Shanghai stock index volatility pulls up the aerospace and brewing sectors among the top gains_stock news_finance_中金在线

The company announced on July 21 that the company’s controlling shareholder Ke Zongqing held 5,578,800 shares of the company to be forced to liquidate, and the number of reduced shares accounted for 0.45% of the company’s total share capital, but Ke Zongqing did not perform the pre-disclosure of the aforementioned passive liquidation. obligation. The Sichuan Securities Regulatory Bureau has taken administrative supervision measures to issue warning letters for the above-mentioned actions and record them in the integrity files of the securities and futures markets.

On October 13, Blue Shield announced that the controlling shareholder Ke Zonggui held 35.1 million shares of the company (accounting for 2.81% of the company’s total share capital) from 10:00 on October 12 to 10:00 on October 13 this year (delayed Except) conduct public auctions. After the auction completed the transfer of shares, Ke Zonggui and Ke Zongqing and their concerted parties held a total of 27.50% of the company’s total share capital, and remained the company’s controlling shareholder and actual controller.

In terms of performance, the company’s third quarterly report shows that in the first three quarters of 2021, Blue Shield achieved revenue of 278 million yuan, a year-on-year decrease of 61.26%, and a net profit loss of 944 million yuan attributable to the parent.


.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy